c-di-AMP signaling plays important role in determining antibiotic tolerance phenotypes of Mycobacterium smegmatis
Open Access
- 30 July 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-13
Abstract
In this study, we probe the role of secondary messenger c-di-AMP in drug tolerance, which includes both persister and resistant mutant characterization of Mycobacterium smegmatis. Specifically, with the use of c-di-AMP null and overproducing mutants, we showed how c-di-AMP plays a significant role in resistance mutagenesis against antibiotics with different mechanisms of action. We elucidated the specific molecular mechanism linking the elevated intracellular c-di-AMP level and high mutant generation and highlighted the significance of non-homology-based DNA repair. Further investigation enabled us to identify the unique mutational landscape of target and non-target mutation categories linked to intracellular c-di-AMP levels. Overall fitness cost of unique target mutations was estimated in different strain backgrounds, and then we showed the critical role of c-di-AMP in driving epistatic interactions between resistance genes, resulting in the evolution of multi-drug tolerance. Finally, we identified the role of c-di-AMP in persister cells regrowth and mutant enrichment upon cessation of antibiotic treatment.Keywords
All Related Versions
Funding Information
- Department of Biotechnology, Ministry of Science and Technology, India (BT/RLF/Re-entry/31/2017)
This publication has 59 references indexed in Scilit:
- Systematic identification of conserved bacterial c-di-AMP receptor proteinsProceedings of the National Academy of Sciences, 2013
- Epistasis between antibiotic resistance mutations drives the evolution of extensively drug-resistant tuberculosisEvolution, Medicine, and Public Health, 2013
- The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune responseNature Immunology, 2012
- Mycobacterium tuberculosis Rv3586 (DacA) Is a Diadenylate Cyclase That Converts ATP or ADP into c-di-AMPPLOS ONE, 2012
- Impact of Fluoroquinolone Resistance Mutations on Gonococcal Fitness and In Vivo Selection for Compensatory MutationsThe Journal of Infectious Diseases, 2012
- Analysis of the role ofBacillus subtilisσMin β‐lactam resistance reveals an essential role for c‐di‐AMP in peptidoglycan homeostasisMolecular Microbiology, 2011
- Resuscitation Promoting Factors: a Family of Microbial Proteins in Survival and Resuscitation of Dormant MycobacteriaIndian Journal of Microbiology, 2011
- cAMP, c-di-GMP, c-di-AMP and now cGMP: bacteria use them all!Molecular Microbiology, 2010
- c-di-AMP Secreted by Intracellular Listeria monocytogenes Activates a Host Type I Interferon ResponseScience, 2010
- The resuscitation‐promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitroMolecular Microbiology, 2007